Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sakharkar, Mrunal"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł :
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
Autorzy :
Sakharkar M; Adimab LLC, Lebanon, NH 03766, USA.
Rappazzo CG; Adimab LLC, Lebanon, NH 03766, USA.
Wieland-Alter WF; Division of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA.
Hsieh CL; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Esterman ES; Adimab LLC, Lebanon, NH 03766, USA.
Kaku CI; Adimab LLC, Lebanon, NH 03766, USA.
Wec AZ; Adimab LLC, Lebanon, NH 03766, USA.
Geoghegan JC; Adimab LLC, Lebanon, NH 03766, USA.
McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Connor RI; Division of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA.
Wright PF; Division of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA.
Walker LM; Adimab LLC, Lebanon, NH 03766, USA. .; Adagio Therapeutics, Inc., Waltham, MA 02451, USA.
Pokaż więcej
Źródło :
Science immunology [Sci Immunol] 2021 Feb 23; Vol. 6 (56).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
B-Lymphocytes/*immunology
COVID-19/*immunology
Adult ; Aged ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Binding Sites ; COVID-19/virology ; Cohort Studies ; Cross Reactions ; Female ; Humans ; Immunologic Memory ; Longitudinal Studies ; Male ; Middle Aged ; SARS-CoV-2/immunology
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.
Autorzy :
Rappazzo CG
Tse LV
Kaku CI
Wrapp D
Sakharkar M
Huang D
Deveau LM
Yockachonis TJ
Herbert AS
Battles MB
O'Brien CM
Brown ME
Geoghegan JC
Belk J
Peng L
Yang L
Scobey TD
Burton DR
Nemazee D
Dye JM
Voss JE
Gunn BM
McLellan JS
Baric RS
Gralinski LE
Walker LM
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2020 Nov 17. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Preprint
Tytuł :
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein.
Autorzy :
Wec AZ; Adimab LLC, Lebanon, NH 03766, USA.
Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Maurer D; Adimab LLC, Lebanon, NH 03766, USA.
Haslwanter D; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Sakharkar M; Adimab LLC, Lebanon, NH 03766, USA.
Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Dieterle ME; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Lilov A; Adimab LLC, Lebanon, NH 03766, USA.
Huang D; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
Tse LV; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Johnson NV; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Hsieh CL; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Nett JH; Adimab LLC, Lebanon, NH 03766, USA.
Champney E; Adimab LLC, Lebanon, NH 03766, USA.
Burnina I; Adimab LLC, Lebanon, NH 03766, USA.
Brown M; Adimab LLC, Lebanon, NH 03766, USA.
Lin S; Adimab LLC, Lebanon, NH 03766, USA.
Sinclair M; Adimab LLC, Lebanon, NH 03766, USA.
Johnson C; Adimab LLC, Lebanon, NH 03766, USA.
Pudi S; Adimab LLC, Lebanon, NH 03766, USA.
Bortz R 3rd; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Wirchnianski AS; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Laudermilch E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Florez C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Fels JM; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
O'Brien CM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Graham BS; Adimab LLC, Lebanon, NH 03766, USA.; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard.; Departments of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Nemazee D; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
Burton DR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard.
Baric RS; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Departments of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Voss JE; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Walker LM; Adimab LLC, Lebanon, NH 03766, USA.
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2020 May 16. Date of Electronic Publication: 2020 May 16.
Typ publikacji :
Preprint
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies